Assertio announces proposed convertible senior notes offering to refinance existing 13% senior secured notes due 2024

Lake forest, ill., aug. 22, 2022 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a specialty pharmaceutical company offering differentiated products to patients, today announced its intention to offer, subject to market and other conditions, $60 million aggregate principal amount of convertible senior notes due 2027 (the “convertible notes”) in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). assertio also expects to grant the initial purchasers of the convertible notes an option to purchase, within a 13-day period beginning on, and including, the date on which the convertible notes are first issued, up to an additional $10 million aggregate principal amount of the convertible notes.
ASRT Ratings Summary
ASRT Quant Ranking